🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Investigators will study whether immediate statin treatment after the onset...
Status
Completed
Location
Hyogo collage of Medicine
Start Date
2015-09
Trial ID
NCT02549846
Treatments Being Tested
Assess efficacy and safety of Omacor® 4g with statin treatment for lowering...
Status
Completed
Location
Bucheon St. Mary's Hospital
Start Date
2009-02
Trial ID
NCT02305355
Treatments Being Tested
The objective of this study is * To evaluate the efficacy of PRC-4016 by a...
Status
Terminated
Location
Medical Affiliated Research Center, Inc.
Start Date
2013-11
Trial ID
NCT01972178
Primary Objective: To demonstrate the reduction of low-density lipoprotein...
Status
Completed
Location
Investigational Site Number 392028
Start Date
2015-11-30
Trial ID
NCT02584504
Treatments Being Tested
Alirocumab (SAR236553/REGN727) is a fully human monoclonal antibody that bi...
Status
Completed
Location
Investigational Site Number 840857
Start Date
2012-07
Trial ID
NCT01644175
Treatments Being Tested
The purpose of this study is to compare the effects of pravastatin and rosu...
Status
Unknown
Location
Yokohama City University Medical Center
Start Date
2011-03
Trial ID
NCT01325818
Treatments Being Tested
In this randomised controlled trial of patients with stable angina and docu...
Status
Completed
Location
Golden Jubilee National Hospital
Start Date
2015-04
Trial ID
NCT02425969
Treatments Being Tested
JS002 is a recombinant humanized anti-PCSK9 monoclonal antibody....
Status
Completed
Location
Fuwai Hospital Chinese Academy of Medical Sciences
Start Date
2019-05-23
Trial ID
NCT04469673
Treatments Being Tested
Compared with standardized western medical drug therapy, this study is main...
Status
Completed
Location
Jilin Province TCM Institute of Chinese Medicine
Start Date
2012-03
Trial ID
NCT01715376
Laropiprant (LRP; Merck \& Co., Inc, Whitehouse Station, NJ, USA) is a pote...
Status
Terminated
Location
Leviev Heart Center, Sheba Medical Center
Start Date
2010-07
Trial ID
NCT01052311
Treatments Being Tested